Medicon Hellas S.A. Logo

Medicon Hellas S.A.

Develops, makes, and sells IVD products, analytical systems & software for healthcare providers.

MEDIC | AT

Overview

Corporate Details

ISIN(s):
GRS424003002
LEI:
21380029I4NIQ9ZXE146
Country:
Greece
Address:
MELITONA 5-7, 15344 GERAKAS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Medicon Hellas S.A. is a leading company in the in-vitro diagnostics (IVD) sector. Its operations encompass the research, development, manufacturing, and sale of proprietary IVD products, including diagnostic reagent kits and bulk materials. The company also imports and distributes automated analytical systems from international manufacturers and develops specialized software for laboratory and medical applications. It serves a broad range of healthcare providers, such as public and private hospitals, clinical labs, and diagnostic centers. Products are exported globally through a network of distributors as both branded items and materials for further processing. The company's activities also include providing diagnostic services and manufacturing a line of cosmetics and personal care products. Medicon Hellas operates under key quality certifications, including ISO 13485, and a manufacturer’s license from the National Medicines Organization.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-29 19:30
Interim Report
Οικονομική έκθεση MEDICON ΕΛΛΑΣ A.E (2025,Εξαμηνιαία,Ενοποιημένη)
Greek (modern) 1.8 MB
2025-06-26 09:11
Notice of Dividend Amount
ΟΡΘΗ ΕΠΑΝΑΛΗΨΗ-ΓΝΩΣΤΟΠΟΙΗΣΗ ΑΠΟΚΟΠΗΣ ΔΙΚΑΙΩΜΑΤΟΣ ΜΕΡΙΣΜΑΤΟΣ / ΠΛΗΡΩΜΗΣ ΜΕΡΙΣΜΑΤ…
Greek (modern) 800.1 KB
2025-06-26 09:10
Declaration of Voting Results & Voting Rights Announcements
ΟΡΘΗ ΕΠΑΝΑΛΗΨΗ-ΑΝΑΚΟΙΝΩΣΗ ΓΙΑ ΤΙΣ ΑΠΟΦΑΣΕΙΣ ΓΕΝΙΚΗΣ ΣΥΝΕΛΕΥΣΗΣ
Greek (modern) 518.3 KB
2025-06-25 16:42
Declaration of Voting Results & Voting Rights Announcements
ΑΝΑΚΟΙΝΩΣΗ ΓΙΑ ΤΙΣ ΑΠΟΦΑΣΕΙΣ ΓΕΝΙΚΗΣ ΣΥΝΕΛΕΥΣΗΣ
Greek (modern) 518.2 KB
2025-05-30 11:14
Pre-Annual General Meeting Information
INVITATION FOR THE ANNUAL GENERAL MEETING 2025
English 490.8 KB

Automate Your Workflow. Get a real-time feed of all Medicon Hellas S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Medicon Hellas S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Medicon Hellas S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America AARD
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America ABBV
ABEONA THERAPEUTICS INC. Logo
Developing AAV-based cell and gene therapies for serious and rare diseases.
United States of America ABEO
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX

Talk to a Data Expert

Have a question? We'll get back to you promptly.